| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 33 |
| 1 | PREDNISOLONE ORAL | 33 |
| 2 | PREDNISOLONE ORAL SOLUTION | 33 |
| 3 | PREDNISONE | 27 |
| 4 | MYCOPHENOLATE MOFETIL | 23 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 23 |
| 6 | METHOTREXATE SODIUM | 18 |
| 7 | METHOTREXATE | 17 |
| 8 | EFGARTIGIMOD ALFA | 16 |
| 9 | METHYLPREDNISOLONE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | APRACLONIDINE | 1 | 0.0090 |
| 1 | EFGARTIGIMOD ALFA | 16 | 0.0040 |
| 2 | PYRIDOSTIGMINE BROMIDE ORAL | 13 | 0.0037 |
| 3 | TOFERSEN | 2 | 0.0035 |
| 4 | LETIBOTULINUMTOXINA-WLBG | 1 | 0.0034 |
| 5 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 6 | MOGAMULIZUMAB-KPKC | 3 | 0.0022 |
| 7 | ONASEMNOGENE ABEPARVOVEC-XIOI | 5 | 0.0022 |
| 8 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 9 | IMIPENEM AND CILASTATIN SODIUM | 3 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 20 | 0.0046 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 3 | 0.0022 |
| 2 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 3 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 4 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 5 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 3 | 0.0007 |
| 6 | Benzothiazole [EPC] | 1 | 0.0004 |
| 7 | Human Immunoglobulin G [EPC] | 9 | 0.0004 |
| 8 | Antisense Oligonucleotide [EPC] | 5 | 0.0004 |
| 9 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |